Topzle Topzle

Pancreatic cancer

Updated: Wikipedia source

Pancreatic cancer

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the non-adenocarcinomas, can also arise from these cells. About 1–2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma. Signs and symptoms of the most-common form of pancreatic cancer may include yellow skin, abdominal or back pain, unexplained weight loss, light-colored stools, dark urine, and loss of appetite. Usually, no symptoms are seen in the disease's early stages, and symptoms that are specific enough to suggest pancreatic cancer typically do not develop until the disease has reached an advanced stage. By the time of diagnosis, pancreatic cancer has often spread to other parts of the body. Pancreatic cancer rarely occurs before the age of 40, and more than half of cases of pancreatic adenocarcinoma occur in those over 70. However, early-onset pancreatic cancer (defined as pancreatic cancer diagnosed in someone <50 years of age) is becoming more prevalent, disproportionally so in younger women. Risk factors for pancreatic cancer include tobacco smoking, obesity, diabetes, and certain rare genetic conditions. About 25% of cases are linked to smoking, and 5–10% are linked to inherited genes. Pancreatic cancer is usually diagnosed by a combination of medical imaging techniques such as ultrasound or computed tomography, blood tests, and examination of tissue samples (biopsy). The disease is divided into stages, from early (stage I) to late (stage IV). Screening the general population has not been found to be effective. The risk of developing pancreatic cancer is lower among non-smokers, and people who maintain a healthy weight and limit their consumption of red or processed meat; the risk is greater for men, smokers, and those with diabetes. There are some studies that link high levels of red meat consumption to increased risk of pancreatic cancer, though meta-analyses typically find no clear evidence of a relationship. Smokers' risk of developing the disease decreases immediately upon quitting, and almost returns to that of the rest of the population after 20 years. Pancreatic cancer can be treated with surgery, radiotherapy, chemotherapy, palliative care, or a combination of these. Treatment options are partly based on the cancer stage. Surgery is the only treatment that can cure pancreatic adenocarcinoma, and may also be done to improve quality of life without the potential for cure. Pain management and medications to improve digestion are sometimes needed. Early palliative care is recommended even for those receiving treatment that aims for a cure. Pancreatic cancer is among the most deadly forms of cancer globally, with one of the lowest survival rates. In 2021, pancreatic cancers of all types resulted in 508,532 (up from 411,600 in 2013) deaths globally.It is the fifth-most-common cause of death from cancer in the United Kingdom, and the third most-common in the United States.

The disease occurs most often in the developed world, where about 70% of the new cases in 2012 originated. Pancreatic adenocarcinoma typically has a very poor prognosis; after diagnosis, 25% of people survive one year and 12% live for five years. For cancers diagnosed early, the five-year survival rate rises to about 20%. Neuroendocrine cancers have better outcomes; at five years from diagnosis, 65% of those diagnosed are living, though survival considerably varies depending on the type of tumor.

Infobox

Specialty
mw- Gastroenterology Hepatology Oncology General surgery
Symptoms
mw- .inline, .inline dl, .inline ol, .inline ul, dl dl, dl ol, dl ul, ol dl, ol ol dd dd dd , dd dt , dd li , dt dd , dt dt , dt li , li dd dd dd , dd dt , dd li , dt dd , dt dt , dt li , li dd dd ol li Yellow skinabdominal or back painunexplained weight losslight-colored stoolsdark urineloss of appetite
Usual onset
40 years of age
Risk factors
Tobacco smokingheavy alcohol intakeobesitydiabetescertain rare genetic conditions
Diagnostic method
Medical imagingblood teststissue biopsy
Prevention
Not smoking, low alcohol intake, maintaining a healthy weight, low red meat diet
Treatment
Surgeryradiotherapychemotherapypalliative care
Prognosis
Five year survival rate 13%
Frequency
393,800 (2015)
Deaths
411,600 (2015)

Tables

· Diagnosis › Histopathology
Pancreatic ductal adenocarcinoma (PDAC)
Pancreatic ductal adenocarcinoma (PDAC)
Cancer type
Pancreatic ductal adenocarcinoma (PDAC)
Relative incidence
90%
Microscopy findings
Glands and desmoplasia
Micrograph
Immunohistochemistry markers
Aberrant p53 SMAD4 loss MUC1 MSLN CA19-9
Genetic alterations
p53 SMAD4 KRAS p16
Pancreatic acinar cell carcinoma (ACC)
Pancreatic acinar cell carcinoma (ACC)
Cancer type
Pancreatic acinar cell carcinoma (ACC)
Relative incidence
1% to 2%
Microscopy findings
Granular appearance
Micrograph
Immunohistochemistry markers
Trypsin Chymotrypsin Lipase
Genetic alterations
p53 SMAD4 APC ARID1A GNAS
Solid pseudopapillary tumor
Solid pseudopapillary tumor
Cancer type
Solid pseudopapillary tumor
Microscopy findings
Discohesive tumor nests surrounded by thin fibrous bands.
Micrograph
Low and high magnification
Immunohistochemistry markers
β-catenin (aberrant nuclear expression) p120 (cytoplasmic stain)
Genetic alterations
Point mutation in exon 3 of β-catenin gene
Adenosquamous carcinoma
Adenosquamous carcinoma
Cancer type
Adenosquamous carcinoma
Relative incidence
1% to 4%
Microscopy findings
Combination of gland-like cells and squamous epithelial cells.
Micrograph
Immunohistochemistry markers
Positive for: CK5/6 CK7 p63 Negative for: CK20 p16 p53
Genetic alterations
KRAS p53
Pancreatic neuroendocrine tumor
Pancreatic neuroendocrine tumor
Cancer type
Pancreatic neuroendocrine tumor
Relative incidence
5%
Microscopy findings
Multiple nests of tumor cells
Micrograph
Gastrinoma
Immunohistochemistry markers
Chromogranin Synaptophysin
Genetic alterations
MEN1 DAXX/ATRX
Pre-cancer below for comparison:
Pre-cancer below for comparison:
Cancer type
Pre-cancer below for comparison:
Precancer:Intraductal papillary mucinous neoplasm (IPMN)
Precancer:Intraductal papillary mucinous neoplasm (IPMN)
Cancer type
Precancer:Intraductal papillary mucinous neoplasm (IPMN)
Relative incidence
3%
Microscopy findings
Mucinous epithelial cells. Growth within the pancreatic ducts.
Micrograph
Immunohistochemistry markers
Mucin 5AC
Genetic alterations
KRAS GNAS
Cancer type
Relative incidence
Microscopy findings
Micrograph
Immunohistochemistry markers
Genetic alterations
Pancreatic ductal adenocarcinoma (PDAC)
90%
Glands and desmoplasia
Aberrant p53 SMAD4 loss MUC1 MSLN CA19-9
p53 SMAD4 KRAS p16
Pancreatic acinar cell carcinoma (ACC)
1% to 2%
Granular appearance
Trypsin Chymotrypsin Lipase
p53 SMAD4 APC ARID1A GNAS
Solid pseudopapillary tumor
Discohesive tumor nests surrounded by thin fibrous bands.
Low and high magnification
β-catenin (aberrant nuclear expression) p120 (cytoplasmic stain)
Point mutation in exon 3 of β-catenin gene
Adenosquamous carcinoma
1% to 4%
Combination of gland-like cells and squamous epithelial cells.
Positive for: CK5/6 CK7 p63 Negative for: CK20 p16 p53
KRAS p53
Pancreatic neuroendocrine tumor
5%
Multiple nests of tumor cells
Gastrinoma
Chromogranin Synaptophysin
MEN1 DAXX/ATRX
Pre-cancer below for comparison:
Precancer:Intraductal papillary mucinous neoplasm (IPMN)
3%
Mucinous epithelial cells. Growth within the pancreatic ducts.
Mucin 5AC
KRAS GNAS
Outcomes in pancreatic cancers according to clinical stage, as of 2014[72] · Prognosis
Exocrine pancreatic cancer
Exocrine pancreatic cancer
Clinical stage
Exocrine pancreatic cancer
U.S. five-year survival (%)for 1992–1998 diagnoses
Neuroendocrine treated with surgery
IA / I
IA / I
Clinical stage
IA / I
U.S. five-year survival (%)for 1992–1998 diagnoses
14
U.S. five-year survival (%)for 1992–1998 diagnoses
61
IB
IB
Clinical stage
IB
U.S. five-year survival (%)for 1992–1998 diagnoses
12
IIA / II
IIA / II
Clinical stage
IIA / II
U.S. five-year survival (%)for 1992–1998 diagnoses
7
U.S. five-year survival (%)for 1992–1998 diagnoses
52
IIB
IIB
Clinical stage
IIB
U.S. five-year survival (%)for 1992–1998 diagnoses
5
III
III
Clinical stage
III
U.S. five-year survival (%)for 1992–1998 diagnoses
3
U.S. five-year survival (%)for 1992–1998 diagnoses
41
IV
IV
Clinical stage
IV
U.S. five-year survival (%)for 1992–1998 diagnoses
1
U.S. five-year survival (%)for 1992–1998 diagnoses
16
Clinical stage
five-year survival (%)for 1992–1998 diagnoses
Exocrine pancreatic cancer
Neuroendocrine treated with surgery
IA / I
14
61
IB
12
IIA / II
7
52
IIB
5
III
3
41
IV
1
16

References

  1. "Pancreatic Cancer Treatment (PDQ®) Patient Version"
    http://www.cancer.gov/cancertopics/pdq/treatment/pancreatic/Patient/page1/AllPages
  2. The New England Journal of Medicine
    https://doi.org/10.1056%2FNEJMra1404198
  3. CA: A Cancer Journal for Clinicians
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769458
  4. Lancet
    https://web.archive.org/web/20150112190623/http://m-learning.zju.edu.cn/G2S/eWebEditor/uploadfile/20111127193405_869876397245.pdf
  5. "Can pancreatic cancer be prevented?"
    http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-prevention
  6. PANCAN
    https://web.archive.org/web/20230304023205/https://pancan.org/news/five-year-pancreatic-cancer-survival-rate-increases-to-12/
  7. The Lancet
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577
  8. The Lancet
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903
  9. "What Is Cancer? Defining Cancer"
    http://www.cancer.gov/cancertopics/cancerlibrary/what-is-cancer
  10. World Cancer Report
    https://archive.org/details/worldcancerrepor0000unse_p0u5/page/412/mode/1up
  11. Oncology
    https://pubmed.ncbi.nlm.nih.gov/28299752
  12. BMJ
    https://doi.org/10.1136%2Fbmj.e2476
  13. Cancers
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12110279
  14. Cancers
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12110279
  15. "Draft Recommendation Statement: Pancreatic Cancer: Screening"
    https://www.uspreventiveservicestaskforce.org/Page/Document/draft-recommendation-statement/pancreatic-cancer-screening1
  16. BMC Cancer
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496157
  17. Frontiers in Nutrition
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565855
  18. British Journal of Cancer
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273353
  19. International Journal of Cancer
    https://doi.org/10.1002%2Fijc.27637
  20. Best Practice & Research. Clinical Gastroenterology
    https://doi.org/10.1016%2Fj.bpg.2013.09.006
  21. Frontiers in Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772166
  22. "Cancer facts and figures – Why we exist"
    http://www.pcrf.org.uk/pages/cancer-table.html
  23. SEER
    https://seer.cancer.gov/statfacts/html/pancreas.html
  24. Pancreatic Cancer Action Network
    https://pancan.org/news/pancreatic-cancer-five-year-survival-rate-increases-to-13/
  25. "Pancreatic Cancer Treatment (PDQ®) Health Professional Version"
    http://www.cancer.gov/cancertopics/pdq/treatment/pancreatic/HealthProfessional/page1/AllPages
  26. Radiographics
    https://doi.org/10.1148%2Frg.313105174
  27. Epidemiology of Chronic Disease
    https://books.google.com/books?id=KJLEIvX4wzoC&pg=PA182
  28. Annals of Oncology
    https://doi.org/10.1093%2Fannonc%2Fmds295
  29. Handbook of Pancreatic Cancer
    https://books.google.com/books?id=NmBB5ZoKkk4C&pg=PA288
  30. DeVita, Hellman, and Rosenberg's Cancer: Cancer: Principles & Practice of Oncology
  31. Cancer and its Management
  32. The Sol Goldman Pancreas Cancer Research Center
    http://pathology.jhu.edu/pancreas/BasicTypes2.php?area=ba
  33. Gastroenterology
    https://doi.org/10.1053%2Fj.gastro.2013.01.073
  34. "WHO classification of tumours of the digestive system – NLM Catalog – NCBI"
    https://www.ncbi.nlm.nih.gov/nlmcatalog/101553728
  35. Current Treatment Options in Oncology
    https://doi.org/10.1007%2Fs11864-011-0172-2
  36. The Medical Subject Headings indexing system refers to "islet cell carcinoma", which is subdivided into gastrinoma, gluc
    https://web.archive.org/web/20160319155137/http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?mode=&term=Carcinoma,+Islet+Cell&field=entry#TreeC04.588.322.475.500
  37. The Sol Goldman Pancreas Cancer Research Center
    http://pathology.jhu.edu/pancreas/TreatmentEndocrine.php?area=tr#PROGNOSIS
  38. American Family Physician
    https://pubmed.ncbi.nlm.nih.gov/24784121
  39. Manual of clinical oncology
    https://archive.org/details/manualofclinical00casc_0
  40. The Lancet. Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795483
  41. Manual for Staging of Cancer
    https://cancerstaging.org/references-tools/deskreferences/Documents/AJCC2ndEdCancerStagingManual.pdf
  42. World Journal of Gastrointestinal Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197429
  43. NHS Choices
    http://www.nhs.uk/Conditions/Cancer-of-the-pancreas/Pages/Causes.aspx
  44. Cancer Causes & Control
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907069
  45. Annals of Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387822
  46. Cancer Causes & Control
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685923
  47. International Journal of Environmental Research and Public Health
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431133
  48. Venturi, S. | Correlation of Diabetes, Salivary gland cancer and Pancreatic Cancer with Iodine and Cesium Radionuclides.
  49. Clinical Therapeutics
    https://doi.org/10.1016%2Fj.clinthera.2016.03.006
  50. Frontiers in Physiology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939680
  51. Pancreatology
    https://doi.org/10.1159%2F000210262
  52. International Journal of Environmental Research and Public Health
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431133
  53. American Cancer Society
    http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
  54. Anticancer Research
    https://pubmed.ncbi.nlm.nih.gov/24403441
  55. Diagnostic Pathology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897815
  56. Current Genomics
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129039
  57. Archives of Pathology & Laboratory Medicine
    https://doi.org/10.5858%2Farpa.2016-0207-RA
  58. www.proteinatlas.org
    https://web.archive.org/web/20200703073444/https://www.proteinatlas.org/humanproteome/pathology/pancreatic+cancer
  59. Science
    https://doi.org/10.1126%2Fscience.aan2507
  60. JAMA
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363152
  61. Current Opinion in Endocrinology, Diabetes and Obesity
    https://doi.org/10.1097%2FMED.0000000000000033
  62. The Journal of Clinical Endocrinology and Metabolism
    https://doi.org/10.1210%2Fjc.2012-1230
  63. World Journal of Surgery
    https://doi.org/10.1007%2Fs00268-008-9908-y
  64. Current Opinion in Gastroenterology
    https://doi.org/10.1097%2FMOG.0b013e328349e30c
  65. Annals of Oncology
    https://doi.org/10.1093%2Fannonc%2Fmds224
  66. "Solid pseudopapillary neoplasm"
    https://www.pathologyoutlines.com/topic/pancreassolidpseudo.html
  67. Cases Journal
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825199
  68. Pathology Outlines
    http://www.pathologyoutlines.com/topic/pancreasipmn.html
  69. Annals of Surgery
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568174
  70. Cancers
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448143
  71. Annals of Oncology
    https://doi.org/10.1093%2Fannonc%2Fmdq165
  72. American Cancer Society
    https://web.archive.org/web/20200810114057/http://www.cancer.org/cancer/pancreatic-cancer.html
  73. Principles and Practice of Surgical Oncology: Multidisciplinary Approach to Difficult Problems
    https://web.archive.org/web/20150206115602/http://lwwoncology.com/Textbook/Toc.aspx?id=11008
  74. "Neuroendocrine tumors, NCCN Guidelines Version 1.2015"
    https://web.archive.org/web/20210424152849/https://www.nccn.org/login?ReturnURL=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fpdf%2Fneuroendocrine.pdf
  75. "Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Health Professional Version"
    http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page1
  76. American Cancer Society
    http://www.cancer.org/healthy/eathealthygetactive/acsguidelinesonnutritionphysicalactivityforcancerprevention/acs-guidelines-on-nutrition-and-physical-activity-for-cancer-prevention-dietand-activity
  77. JAMA
    https://doi.org/10.1001%2Fjama.2019.10232
  78. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145762
  79. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145761
  80. Gut
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295005
  81. Medicine
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940047
  82. The Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11095847
  83. Annals of Surgery
    https://doi.org/10.1097%2FSLA.0b013e31823ac299
  84. NCCN Guidelines
    https://web.archive.org/web/20070208002943/http://www.nccn.org/professionals/physician_gls/PDF/pancreatic.pdf
  85. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202352
  86. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138454
  87. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110569
  88. PLOS Medicine
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857873
  89. Annals of Surgical Oncology
    https://doi.org/10.1245%2Fs10434-014-4307-0
  90. Current Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117630
  91. Cancer Letters
    https://doi.org/10.1016%2Fj.canlet.2014.12.004
  92. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138459
  93. The Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458011
  94. Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923262
  95. Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750387
  96. Cochrane Database of Systematic Reviews
    https://doi.org/10.1002%2F14651858.CD004379.pub2
  97. Annals of Oncology
    https://doi.org/10.1093%2Fannonc%2Fmdt239
  98. Oncology
    https://pubmed.ncbi.nlm.nih.gov/24683721
  99. UpToDate
    http://www.uptodate.com/contents/chemotherapy-for-advanced-exocrine-pancreatic-cancer
  100. National Cancer Institute
    http://www.cancer.gov/cancertopics/druginfo/fda-erlotinib-hydrochloride#Anchor-Pancreati-44285
  101. Expert Review of Gastroenterology & Hepatology
    https://doi.org/10.1586%2F17474124.2014.925799
  102. The Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11619003
  103. Lancet
    https://doi.org/10.1016%2FS0140-6736%2801%2906651-X
  104. The New England Journal of Medicine
    https://doi.org/10.1056%2FNEJMoa032295
  105. NBC News
    https://www.nbcnews.com/health/cancer/pancreatic-cancer-vaccine-mrna-treatment-trial-rcna192702
  106. www.cbsnews.com
    https://www.cbsnews.com/news/pancreatic-cancer-vaccine-clinical-trial-memorial-sloan-kettering/
  107. Nature
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11946889
  108. Nature
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171177
  109. Neuroendocrinology
    https://doi.org/10.1159%2F000335587
  110. Neuroendocrinology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701449
  111. Neuroendocrinology
    https://doi.org/10.1159%2F000335597
  112. Annals of Translational Medicine
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200651
  113. Medscape Medical News
    http://www.medscape.com/viewarticle/836729
  114. Everolimus Approved for Pancreatic Neuroendocrine Tumors Archived 16 July 2016 at the Wayback Machine The ASCO Post. 15
    http://www.cancer.gov/about-cancer/treatment/drugs/fda-everolimus
  115. National Cancer Institute. Cancer Drug Information. FDA Approval for Sunitinib Malate Archived 5 January 2015 at the Way
    http://www.cancer.gov/cancertopics/druginfo/fda-sunitinib-malate
  116. Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach
    http://www.cancernetwork.com/cancer-management/pancreatic/article/10165/1802606
  117. Clinical Oncology
    https://doi.org/10.1016%2Fj.clon.2011.12.003
  118. Endocrine Practice
    https://doi.org/10.4158%2FEP14373.RA
  119. Seminars in Nuclear Medicine
    https://doi.org/10.1053%2Fj.semnuclmed.2009.10.004
  120. Thoracic Surgery Clinics
    https://doi.org/10.1016%2Fj.thorsurg.2014.04.005
  121. Cancer Chemotherapy and Pharmacology
    https://doi.org/10.1007%2Fs00280-014-2642-2
  122. Annals of Surgical Oncology
    https://doi.org/10.1245%2Fs10434-014-4145-0
  123. "Palliative or Supportive Care"
    http://www.cancer.org/treatment/treatmentsandsideeffects/palliativecare/index
  124. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130847
  125. "If treatment for pancreatic cancer stops working"
    https://web.archive.org/web/20141022070844/http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-after-no-longer-working
  126. The Cochrane Database of Systematic Reviews
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464722
  127. American Cancer Society
    http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf
  128. CA: A Cancer Journal for Clinicians
    https://doi.org/10.3322%2Fcanjclin.57.1.43
  129. American Cancer Society
    http://www.cancer.org/cancer/pancreaticcancer/detailedguide/pancreatic-cancer-key-statistics
  130. Cancer Research UK
    http://www.cancerresearchuk.org/cancer-info/cancerstats/types/pancreas/incidence/#Lifetime
  131. American Journal of Surgery
    https://doi.org/10.1016%2F0002-9610%2883%2990286-6
  132. HPB
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103093
  133. Annals of Surgery
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570590
  134. Surgery
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806095
  135. American Cancer Society
    https://www.cancer.org/cancer/pancreatic-cancer/about/new-research.html
  136. Cancer Research UK
    http://www.cancerresearchuk.org/cancer-help/type/pancreatic-cancer/treatment/whats-new-in-pancreatic-cancer-research
  137. "Australian Pancreatic Genome Initiative"
    http://www.pancreaticcancer.net.au/
  138. Nature
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530898
  139. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011662
  140. Metabolites
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11278541
  141. Clinical Genetics
    https://doi.org/10.1111%2Fcge.12536
  142. The Journal of Surgical Research
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559279
  143. European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer (EUROPAC)
    https://web.archive.org/web/20140726031739/http://www.europac-org.eu/
  144. Best Practice & Research. Clinical Gastroenterology
    https://doi.org/10.1016%2Fj.bpg.2013.11.011
  145. Current Problems in Cancer
    https://doi.org/10.1016%2Fj.currproblcancer.2013.10.002
  146. European Journal of Surgical Oncology
    https://doi.org/10.1016%2Fj.ejso.2014.08.480
  147. Annals of Oncology
    https://doi.org/10.1093%2Fannonc%2Fmdu013
  148. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138462
  149. World Journal of Gastroenterology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145755
  150. Journal of Hematology & Oncology
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151541
  151. Oncolytic Virotherapy
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918362
  152. Molecular Cancer
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065152
  153. JCI Insight
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10906452
  154. "TUMAGNOSTIC (CP506-001) Phase 1-2a clinical trial for CP-506 that is a drug specific for solid tumours and is activated at low concentrations of oxygen"
    https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-000423-12/NL
  155. Hormone Related Cancer Mechanistic and Nanomedicines
    https://link.springer.com/chapter/10.1007/978-981-19-5558-7_8
Image
Source:
Tip: Wheel or +/− to zoom, drag to pan, Esc to close.